183 related articles for article (PubMed ID: 30657702)
21. Caenorhabditis elegans in high-throughput screens for anti-infective compounds.
Peterson ND; Pukkila-Worley R
Curr Opin Immunol; 2018 Oct; 54():59-65. PubMed ID: 29935375
[TBL] [Abstract][Full Text] [Related]
22. Microfluidic system for on-chip high-throughput whole-animal sorting and screening at subcellular resolution.
Rohde CB; Zeng F; Gonzalez-Rubio R; Angel M; Yanik MF
Proc Natl Acad Sci U S A; 2007 Aug; 104(35):13891-5. PubMed ID: 17715055
[TBL] [Abstract][Full Text] [Related]
23. Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.
Kankala RK; Wang SB; Chen AZ
Curr Pharm Des; 2018; 24(45):5354-5366. PubMed ID: 30799783
[TBL] [Abstract][Full Text] [Related]
24. Caenorhabditis elegans: a versatile platform for drug discovery.
Artal-Sanz M; de Jong L; Tavernarakis N
Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
[TBL] [Abstract][Full Text] [Related]
25. High-throughput in vivo genetic and drug screening using femtosecond laser nano-surgery, and microfluidics.
Rohde C; Gilleland C; Samara C; Zeng F; Yanik MF
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():2642. PubMed ID: 19163246
[TBL] [Abstract][Full Text] [Related]
26. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
[TBL] [Abstract][Full Text] [Related]
27. Microfluidic cell chips for high-throughput drug screening.
Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
[TBL] [Abstract][Full Text] [Related]
28. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
29.
Romussi S; Giunti S; Andersen N; De Rosa MJ
Expert Opin Drug Discov; 2024 May; 19(5):565-585. PubMed ID: 38509691
[TBL] [Abstract][Full Text] [Related]
30. Advances in microfluidics for drug discovery.
Lombardi D; Dittrich PS
Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
[TBL] [Abstract][Full Text] [Related]
31. Advances of droplet-based microfluidics in drug discovery.
Wang Y; Chen Z; Bian F; Shang L; Zhu K; Zhao Y
Expert Opin Drug Discov; 2020 Aug; 15(8):969-979. PubMed ID: 32352844
[TBL] [Abstract][Full Text] [Related]
32. Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity.
Mathew MD; Mathew ND; Miller A; Simpson M; Au V; Garland S; Gestin M; Edgley ML; Flibotte S; Balgi A; Chiang J; Giaever G; Dean P; Tung A; Roberge M; Roskelley C; Forge T; Nislow C; Moerman D
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005058. PubMed ID: 27755544
[TBL] [Abstract][Full Text] [Related]
33. High-throughput screening in the C. elegans nervous system.
Kinser HE; Pincus Z
Mol Cell Neurosci; 2017 Apr; 80():192-197. PubMed ID: 27265309
[TBL] [Abstract][Full Text] [Related]
34. Droplet microfluidics for characterizing the neurotoxin-induced responses in individual Caenorhabditis elegans.
Shi W; Wen H; Lu Y; Shi Y; Lin B; Qin J
Lab Chip; 2010 Nov; 10(21):2855-63. PubMed ID: 20882233
[TBL] [Abstract][Full Text] [Related]
35. Whole animal HTS of small molecules for antifungal compounds.
Muhammed M; Arvanitis M; Mylonakis E
Expert Opin Drug Discov; 2016; 11(2):177-84. PubMed ID: 26593386
[TBL] [Abstract][Full Text] [Related]
36. Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.
Silverman GA; Luke CJ; Bhatia SR; Long OS; Vetica AC; Perlmutter DH; Pak SC
Pediatr Res; 2009 Jan; 65(1):10-8. PubMed ID: 18852689
[TBL] [Abstract][Full Text] [Related]
37. Microfluidics-assisted in vitro drug screening and carrier production.
Tsui JH; Lee W; Pun SH; Kim J; Kim DH
Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1575-88. PubMed ID: 23856409
[TBL] [Abstract][Full Text] [Related]
38. Microengineering methods for cell-based microarrays and high-throughput drug-screening applications.
Xu F; Wu J; Wang S; Durmus NG; Gurkan UA; Demirci U
Biofabrication; 2011 Sep; 3(3):034101. PubMed ID: 21725152
[TBL] [Abstract][Full Text] [Related]
39. Is Caenorhabditis elegans the Magic Bullet for Anthelminthic Drug Discovery?
Keiser J
Trends Parasitol; 2015 Oct; 31(10):455-456. PubMed ID: 26422771
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
